Compare Divis Laboratories with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ADVANCED ENZYME TECHNOLOGIES DIVIS LABORATORIES/
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x 32.7 23.8 137.1% View Chart
P/BV x 10.4 3.1 340.9% View Chart
Dividend Yield % 0.5 0.2 241.8%  

Financials

 DIVIS LABORATORIES   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
ADVANCED ENZYME TECHNOLOGIES
Mar-21
DIVIS LABORATORIES/
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs3,913417 939.5%   
Low Rs1,824129 1,410.8%   
Sales per share (Unadj.) Rs262.544.9 584.5%  
Earnings per share (Unadj.) Rs74.713.6 551.4%  
Cash flow per share (Unadj.) Rs84.416.1 524.1%  
Dividends per share (Unadj.) Rs20.000.60 3,333.3%  
Avg Dividend yield %0.70.2 317.1%  
Book value per share (Unadj.) Rs350.186.6 404.1%  
Shares outstanding (eoy) m265.47111.73 237.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x10.96.1 179.8%   
Avg P/E ratio x38.420.1 190.6%  
P/CF ratio (eoy) x34.017.0 200.6%  
Price / Book Value ratio x8.23.1 260.1%  
Dividend payout %26.84.4 604.6%   
Avg Mkt Cap Rs m761,51730,491 2,497.5%   
No. of employees `000NANA-   
Total wages/salary Rs m8,258871 948.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m69,6945,018 1,388.8%  
Other income Rs m62788 708.4%   
Total revenues Rs m70,3215,107 1,377.0%   
Gross profit Rs m28,6112,325 1,230.6%  
Depreciation Rs m2,556284 899.6%   
Interest Rs m2126 82.2%   
Profit before tax Rs m26,6602,104 1,267.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,818589 1,157.3%   
Profit after tax Rs m19,8431,515 1,310.1%  
Gross profit margin %41.146.3 88.6%  
Effective tax rate %25.628.0 91.3%   
Net profit margin %28.530.2 94.3%  
BALANCE SHEET DATA
Current assets Rs m67,9065,161 1,315.8%   
Current liabilities Rs m17,284676 2,558.3%   
Net working cap to sales %72.689.4 81.3%  
Current ratio x3.97.6 51.4%  
Inventory Days Days10102 9.4%  
Debtors Days Days87863 1,399.3%  
Net fixed assets Rs m45,9636,297 729.9%   
Share capital Rs m531223 237.6%   
"Free" reserves Rs m92,4159,457 977.2%   
Net worth Rs m92,9469,680 960.2%   
Long term debt Rs m099 0.0%   
Total assets Rs m113,86911,458 993.8%  
Interest coverage x1,270.583.3 1,524.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.4 139.7%   
Return on assets %17.413.4 129.8%  
Return on equity %21.315.6 136.4%  
Return on capital %28.721.8 131.8%  
Exports to sales %012.9 0.0%   
Imports to sales %18.85.9 317.7%   
Exports (fob) Rs mNA648 0.0%   
Imports (cif) Rs m13,127298 4,412.2%   
Fx inflow Rs m58,877648 9,084.8%   
Fx outflow Rs m13,341298 4,484.4%   
Net fx Rs m45,536351 12,988.8%   
CASH FLOW
From Operations Rs m19,4691,629 1,195.2%  
From Investments Rs m751-260 -288.6%  
From Financial Activity Rs m-349-263 132.6%  
Net Cashflow Rs m19,8721,093 1,818.8%  

Share Holding

Indian Promoters % 51.9 12.2 427.5%  
Foreign collaborators % 0.0 40.6 -  
Indian inst/Mut Fund % 36.8 24.9 147.6%  
FIIs % 18.5 18.0 102.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 47.3 101.6%  
Shareholders   309,397 86,573 357.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 111 Points Lower, Nifty Holds 15,750; ONGC, Reliance Crash, while ITC & Bajaj Twins Gain 4%(Closing)

After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.

Related Views on News

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

How to Find the Next Multibagger Stock in the Market(Profit Hunter)

Jun 17, 2022

The #1 make or break factor in your portfolio you shouldn't ignore.

Is the Market Correction Over?(Fast Profits Daily)

Jun 17, 2022

In this video I'll show you why I think the market correction could be coming to an end.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Jul 1, 2022 03:31 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS